CFG boosts its buyback plan to $1.5B, underscoring confidence in its capital strength and long-term strategy.
PROVIDENCE, R.I.--(BUSINESS WIRE)--As part of its commitment to empowering customers at every stage of their financial journey, Citizens has launched a new suite of Mastercard credit cards designed to address the distinct financial needs and preferences of today's consumers. Built on years of customers' insights and feedback, the new credit cards offer tailored features that range from establishing credit to maximizing rewards and lifestyle benefits. As customers grow in financial experience an.
The bank's ten-year median net interest margin is steady at 3.5%, reflecting the bank's diversification and consistent loan quality. The historical loan-to-deposit ratio implies a solid funding profile. The bank has strong ROE compared to their competition.
Total revenues of $55.7 million in Q1 2025, from $57.7 million in Q1 2024Adjusted total revenues of $58.5 million in Q1 2025, up from $56.7 million in Q1 2024 $1.8 million loss before federal income tax in Q1 2025, from $4.9 million income in Q1 2024 Adjusted income before federal income tax of $1.1 million in Q1 2025, from $4.0 million in Q1 2024 Book value per Class A share of $4.37 at March 31 2025, from $3.94 at March 31, 2024Adjusted book value per Class A share of $6.12 at March 31, 2025, from $5.95 at March 31, 2024 Austin, Texas--(Newsfile Corp. - May 8, 2025) - Citizens, Inc. (NYSE: CIA), a leading diversified financial services company specializing in life, living benefits, and final expense insurance, today reported results for the first quarter ended March 31, 2025. "We continue to deliver on our strategic commitments with our tenth consecutive quarter of year-over-year growth in first year premiums.
PROVIDENCE, R.I.--(BUSINESS WIRE)--Citizens Financial Group, Inc. (NYSE: CFG) announced today that Chairman and Chief Executive Officer Bruce Van Saun will participate in the Bernstein 41st Annual Strategic Decisions Conference 2025 to be held on Friday, May 30, 2025 at 9:00 am ET. The live webcast will be available at Click Here under Events & Presentations. About Citizens Financial Group, Inc. Citizens Financial Group, Inc. is one of the nation's oldest and largest.
BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease and cancer, today announced that it will participate in a fireside chat at the Citizens Life Sciences Conference being held in New York, May 7-8, 2025.
CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Citizens Life Sciences Conference, being held May 7-8, 2025, in New York, NY.
HONG KONG and SHANGHAI , May 3, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group", HKEX: 2318; SSE: 601318) has established the "502 Overseas Emergency Assistance Task Force" to coordinate emergency responses and assistance for Chinese citizens affected by the May 1 traffic accident near Yellowstone National Park in the US.
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform today announced that Company management is scheduled to present at the Citizens (JMP) Life Sciences Conference in New York City on Thursday, May 8 at 11:30 AM EDT.
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today announced that Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in a fireside chat at The Citizens Life Sciences Conference on Thursday, May 8, 2025, at 10:00 a.m. ET in New York, NY. A live webcast of the presentation will be available on the Nuvation Bio website at Click Here An ar.
WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking place in New York on May 7, 2025.
BETHESDA, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Gene Mack, President and CEO of Gain, will present and participate in one-on-one meetings at The Citizens Life Sciences Conference, being held May 7th-8th in New York City, NY.